PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 2, 20260 citationsOpen Access

Formulation and Evaluation of Esomeprazole Oral Dispersible Tablets

View Full Paper
PTPalamakula Vijayalakshmi1, Vattikuti Uday Kiran1, Dr. Atthapu Thirupathaiah2*

Key Points

  • This study aims to formulate esomeprazole oral dispersible tablets to enhance bioavailability and reduce side effects.
  • Precompression blends were characterized for various properties including flowability and compressibility.
  • Esomeprazole tablets were formulated using disintegrants like Primojel, Crospovidone, and Sodium-starch glycolate at varying concentrations.
  • Dissolution tests were conducted to evaluate the performance of the tablets.
  • F3 formulation with Primojel exhibited a drug release of 98.12% within 30 minutes, indicating superior performance.
  • All formulations passed quality control tests, ensuring their reliability for use.

Abstract

The aim of this study is to formulate and significantly improve the bioavailability and reduce the side effects of Mouth dissolving tablets Esomeprazole. The precompression blends of Esomeprazole were characterized with respect to angle of repose, bulk density, tapped density, Carr’s index and Hausner’s ratio. The precompression blend of all the batches indicates well to fair flowability and compressibility. Mouth dissolving tablets were prepared with various disintegrants like Primojel, Crospovidone and Sodium-starch glycolate at different concentration ratios and were compressed into tablets. The formulated tablets were evaluated for various quality control parameters. The tablets were passed all tests. Among all the formulations F3 formulation containing, drug and Primojel showed good result that is 98.12 % in 30 min. Hence from the dissolution data it was evident that F3 formulation is the better formulation. By conducting further studies like invitro studies, preclinical and clinical studies we can commercialize the product.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Palamakula Vijayalakshmi1, Vattikuti Uday Kiran1, Dr. Atthapu Thirupathaiah2* (2026) studied this question.

synapsesocial.com/papers/69f594fc71405d493affff15https://doi.org/10.5281/zenodo.19912846
Ask AI
Helpful
Bookmark
Share
View Full Paper